I caught up with the Remidio team at HLTH Europe in Amsterdam, June 2025. Big thanks to Nirupa Rao and Saurabh from the Remidio team, and Harry Salt from Future Medicine AI for his equipment and for being such a great guinea pig to demo the tool.
Remidio have developed a portable, AI-powered tool that enables community health workers across India to screen for diabetic retinopathy, glaucoma, and age-related macular degeneration.
The device has already reached over 40 million people across India. No dilation required, no specialist training needed. Their solution was built for last mile impact in rural communities. They came to Health Europe because they’re seeing the same access issues in rural parts of Europe and the US, and there’s clearly a market to serve and impact in high income settings too.
Stay tuned for a full deep dive on the podcast.
Check out Remidio here: https://www.remidio.com/en-us
